Aiforia Technologies Plc – Managers’ Transactions – Joseph Bernardo

Aiforia Technologies Plc, Company release, Managers’ Transaction, July 2, 2025 5:00 p.m. EEST

Aiforia Technologies Plc has received a notification from Joseph Bernardo, Aiforia Technologies Plc's Board member and his controlled company Greyt Solutions LLC, of a transaction made with Aiforia Technologies Plc’s financial instrument, according to the Article 19 of EU Market Abuse Regulation. Detailed information about the transaction is given here under.

Aiforia Technologies Plc - Managers' Transactions

____________________________________________

Person subject to the notification requirement
Name: Greyt Solutions LLC
Position: Closely associated person
(X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer
Name: Joseph Bernardo
Position: Member of the Board
Issuer: Aiforia Technologies Plc
LEI: 743700TJRVBX7420Y723
Notification type: INITIAL NOTIFICATION
Reference number: 115130/8/12

____________________________________________

Transaction date: 2025-06-30
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Aiforia Technologies 2025 A
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 99,400 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 99,400 Volume weighted average price: 0 EUR

____________________________________________

Transaction date: 2025-06-30
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Aiforia Technologies 2025 B
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 99,400 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 99,400 Volume weighted average price: 0 EUR

____________________________________________

Transaction date: 2025-06-30
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Aiforia Technologies 2025 C
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 99,400 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 99,400 Volume weighted average price: 0 EUR

Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358 405 009 878
https://investors.aiforia.com/

Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi

About Aiforia 
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com